OXB — Oxford BioMedica Cashflow Statement
0.000.00%
Last trade - 00:00- £202.50m
- £212.27m
- £139.99m
- 15
- 32
- 19
- 10
Annual cashflow statement for Oxford BioMedica, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 13.9 | -14.5 | -5.69 | 19.9 | -46 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | -6.77 | 4.13 | 4.12 | 5.03 | 1.53 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1.36 | 1.04 | -5.15 | -11.9 | 5.47 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 12.9 | -3.51 | 3.12 | 25.5 | -12.6 |
| Capital Expenditures | -10.1 | -25.8 | -13.4 | -9.46 | -16.3 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0.052 | 6.38 | 2.56 | 0 | -40.2 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -10.1 | -19.4 | -10.8 | -9.46 | -56.5 |
| Financing Cash Flow Items | -6.04 | -4.15 | -1.72 | -0.873 | -13.9 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 15.1 | 6.91 | 38.2 | 46.2 | 98.6 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 17.9 | -16 | 30.5 | 62.2 | 32.3 |